{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:54:08Z","timestamp":1766134448148,"version":"3.48.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,19]]},"DOI":"10.7759\/cureus.99593","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:49:53Z","timestamp":1766134193000},"source":"Crossref","is-referenced-by-count":0,"title":["Non-small Cell Lung Cancer in Women: Experience From the National Institute of Oncology, Rabat, Morocco"],"prefix":"10.7759","author":[{"given":"Boutaina","family":"Cherkaoui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibrahim","family":"El Ghissassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Intissar","family":"Belrhali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samia","family":"El Hilali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saber","family":"Boutayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Mrabti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2019.10.001","article-title":"Lung cancer 2020 epidemiology, etiology, and prevention","volume":"41","author":"Bade BC","year":"2020","unstructured":"Bade BC, Dela Cruz CS. Lung cancer 2020 epidemiology, etiology, and prevention. Clin Chest Med. 2020, 41:1-24. 10.1016\/j.ccm.2019.10.001","journal-title":"Clin Chest Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2004.01.006","article-title":"Gender and lung cancer","volume":"25","author":"Rivera MP","year":"2004","unstructured":"Rivera MP, Stover DE. Gender and lung cancer. Clin Chest Med. 2004, 25:391-400. 10.1016\/j.ccm.2004.01.006","journal-title":"Clin Chest Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn389","article-title":"Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control","volume":"100","author":"Jemal A","year":"2008","unstructured":"Jemal A, Thun MJ, Ries LA, et al.. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008, 100:1672-94. 10.1093\/jnci\/djn389","journal-title":"J Natl Cancer Inst"},{"key":"ref4","article-title":"Lung cancer epidemiology and risk factors in Asia and Africa","volume":"8","author":"Lam WK","year":"2004","unstructured":"Lam WK, White NW, Chan-Yeung MM. Lung cancer epidemiology and risk factors in Asia and Africa. Int J Tuberc Lung Dis. 2004, 8:1045-57.","journal-title":"Int J Tuberc Lung Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.05.021","article-title":"The internationnal epidemiology of lung cancer: latest trends, disparities, and tumor characteristics","volume":"11","author":"Cheng TY","year":"2016","unstructured":"Cheng TY, Cramb SM, Baade PD, Youlden DR, Nwogu C, Reid ME. The internationnal epidemiology of lung cancer: latest trends, disparities, and tumor characteristics. J Thorac Oncol. 2016, 11:1653-71. 10.1016\/j.jtho.2016.05.021","journal-title":"J Thorac Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.02.016","article-title":"Lung cancer in the Middle East and North Africa Region","volume":"14","author":"Jazieh AR","year":"2019","unstructured":"Jazieh AR, Algwaiz G, Errihani H, Elghissassi I, Mula-Hussain L, Bawazir AA, Gaafar R. Lung cancer in the Middle East and North Africa Region. J Thorac Oncol. 2019, 14:1884-91. 10.1016\/j.jtho.2019.02.016","journal-title":"J Thorac Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","author":"Ferlay J","year":"2021","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Pi\u00f1eros M, Znaor A, Bray F. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021, 10.1002\/ijc.33588","journal-title":"Int J Cancer"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2012-0263-RA","article-title":"Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification","volume":"137","author":"Travis WD","year":"2013","unstructured":"Travis WD, Brambilla E, Noguchi M, et al.. Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer\/American Thoracic Society\/European Respiratory Society classification. Arch Pathol Lab Med. 2013, 137:668-84. 10.5858\/arpa.2012-0263-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2010.12.015","article-title":"Epidemiological novelties in lung cancer (Article in French)","volume":"28","author":"Quoix E","year":"2011","unstructured":"Quoix E, Lemari\u00e9 E. Epidemiological novelties in lung cancer (Article in French). Rev Mal Respir. 2011, 28:1048-58. 10.1016\/j.rmr.2010.12.015","journal-title":"Rev Mal Respir"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/LCTT.S37319","article-title":"Lung cancer in women","volume":"3","author":"Barrera-Rodriguez R","year":"2012","unstructured":"Barrera-Rodriguez R, Morales-Fuentes J. Lung cancer in women. Lung Cancer (Auckl). 2012, 3:79-89. 10.2147\/LCTT.S37319","journal-title":"Lung Cancer (Auckl)"},{"key":"ref11","article-title":"Female lung cancer in Marrakech","volume":"2","author":"Khouchani M","year":"2013","unstructured":"Khouchani M, SelmajiI , Elmorabit B, Ismaili N, Elomrani A, Belbaraka R, Tahri A. Female lung cancer in Marrakech. Clin Cancer Invest J. 2013, 2:128-31.","journal-title":"Clin Cancer Invest J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31818020eb","article-title":"The International Epidemiology of Lung Cancer: geographical distribution and secular trends","volume":"3","author":"Youlden DR","year":"2008","unstructured":"Youlden DR, Cramb SM, Baade PD. The International Epidemiology of Lung Cancer: geographical distribution and secular trends. J Thorac Oncol. 2008, 3:819-31. 10.1097\/JTO.0b013e31818020eb","journal-title":"J Thorac Oncol"},{"key":"ref13","article-title":"Global Cancer Statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara BS","year":"2023","unstructured":"Chhikara BS, Parang K. Global Cancer Statistics 2022: the trends projection analysis. Chem Biology Lett. 2023, 10:451.","journal-title":"Chem Biology Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta JA","year":"2019","unstructured":"Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019, 85:10.5334\/aogh.2419","journal-title":"Ann Glob Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(00)70213-3","article-title":"Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. The","volume":"119","author":"De Perrot M","year":"2000","unstructured":"De Perrot M, Licker M, Bouchardy, et al.. Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinoma. The. J Thoracic Cardiovasc Surg. 2000, 119:21-6. 10.1016\/s0022-5223(00)70213-3","journal-title":"J Thoracic Cardiovasc Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv044.08","article-title":"Sex differences in presentation, management and prognosis of moroccan patients with non-small cell lung 47 carcinoma: a retrospective analysis of 224 cases","volume":"1","author":"Amaadour L","year":"2015","unstructured":"Amaadour L, Boudahna L, Benbrahim Z, Arifi S, Mellas N. Sex differences in presentation, management and prognosis of moroccan patients with non-small cell lung 47 carcinoma: a retrospective analysis of 224 cases . Ann Oncol. 2015, 1:6-9. 10.1093\/annonc\/mdv044.08","journal-title":"Ann Oncol"},{"key":"ref17","article-title":"Non-small cell lung carcinoma in women: a retrospective cohort study in Indonesia","volume":"50","author":"Sutandyo N","year":"2018","unstructured":"Sutandyo N, Suratman E. Non-small cell lung carcinoma in women: a retrospective cohort study in Indonesia. Acta Med Indones. 2018, 50:291-8.","journal-title":"Acta Med Indones"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.jto.0000284124.89325.a6","article-title":"Non-small-cell lung cancer in women: clinical and molecular aspects","volume":"2","author":"Baldini E","year":"2007","unstructured":"Baldini E, Melfi F, Boldrini L, et al.. Non-small-cell lung cancer in women: clinical and molecular aspects. J Thoracic Oncol. 2007, 2:743. 10.1097\/01.jto.0000284124.89325.a6","journal-title":"J Thoracic Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s13104-015-1503-3","article-title":"Smoking, passive smoking and lung cancer cell types among women in Morocco: analysis of epidemiological profiling of 101 cases","volume":"8","author":"Zakkouri FA","year":"2015","unstructured":"Zakkouri FA, Saloua O, Halima A, Rachid R, Hind M, Hassan E. Smoking, passive smoking and lung cancer cell types among women in Morocco: analysis of epidemiological profiling of 101 cases. BMC Res Notes. 2015, 8:530. 10.1186\/s13104-015-1503-3","journal-title":"BMC Res Notes"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.27477","article-title":"What proportion of lung cancer in never-smokers can be attributed to known risk factors?","volume":"131","author":"Sisti J","year":"2012","unstructured":"Sisti J, Boffetta P. What proportion of lung cancer in never-smokers can be attributed to known risk factors?. Int J Cancer. 2012, 131:265-75. 10.1002\/ijc.27477","journal-title":"Int J Cancer"},{"key":"ref21","article-title":"Passive smoking and bronchial cancer: a difficult relation to establish (Article in French)","volume":"52","author":"Charloux A","year":"1996","unstructured":"Charloux A, Quoix E, Pauli G. Passive smoking and bronchial cancer: a difficult relation to establish (Article in French). Rev Pneumol Clin. 1996, 52:227-34.","journal-title":"Rev Pneumol Clin"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2105\/ajph.82.11.1525","article-title":"Passive smoking and lung cancer in nonsmoking women","volume":"82","author":"Brownson RC","year":"1992","unstructured":"Brownson RC, Alavanja MC, Hock ET, Loy TS. Passive smoking and lung cancer in nonsmoking women. Am J Public Health. 1992, 82:1525-30. 10.2105\/ajph.82.11.1525","journal-title":"Am J Public Health"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-1166","article-title":"Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study","volume":"20","author":"Shiels MS","year":"2011","unstructured":"Shiels MS, Albanes D, Virtamo J, Engels EA. Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev. 2011, 20:672-8. 10.1158\/1055-9965.EPI-10-1166","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2021.09.060","article-title":"Lung cancer in women","volume":"114","author":"Tsai LL","year":"2022","unstructured":"Tsai LL, Chu NQ, Blessing WA, Moonsamy P, Colson YL. Lung cancer in women. Ann Thorac Surg. 2022, 114:1965-73. 10.1016\/j.athoracsur.2021.09.060","journal-title":"Ann Thorac Surg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2012.01.038","article-title":"Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium","volume":"48","author":"Cot\u00e9 ML","year":"2012","unstructured":"Cot\u00e9 ML, Liu M, Bonassi S, et al.. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer. 2012, 48:1957-68. 10.1016\/j.ejca.2012.01.038","journal-title":"Eur J Cancer"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2004.02.010","article-title":"Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG)","volume":"45","author":"Grivaux M","year":"2004","unstructured":"Grivaux M, Breton JL, Bombaron P, et al.. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG). Lung Cancer. 2004, 45:279-87. 10.1016\/j.lungcan.2004.02.010","journal-title":"Lung Cancer"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","year":"2014","unstructured":"Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014, 511.543-50. 10.1038\/nature13385","journal-title":"Nature"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.09.008","article-title":"Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research","volume":"55","author":"Belani CP","year":"2007","unstructured":"Belani CP, Marts S, Schiller J, Socinski MA. Women and lung cancer: epidemiology, tumor biology, and emerging trends in clinical research. Lung Cancer. 2007, 55:15-23. 10.1016\/j.lungcan.2006.09.008","journal-title":"Lung Cancer"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.23.2009","article-title":"Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women","volume":"91","author":"Bennett WP","year":"1999","unstructured":"Bennett WP, Alavanja MC, Blomeke B, et al.. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women. J Natl Cancer Inst. 1999, 91:2009-14. 10.1093\/jnci\/91.23.2009","journal-title":"J Natl Cancer Inst"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2190","article-title":"Lung cancer in never smokers--a different disease","volume":"7","author":"Sun S","year":"2007","unstructured":"Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007, 7:778-90. 10.1038\/nrc2190","journal-title":"Nat Rev Cancer"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2478\/bjmg-2018-0022","article-title":"The frequency of EGFR and KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy","volume":"21","author":"A D","year":"2018","unstructured":"A D, A Y, N K, et al.. The frequency of EGFR and KRAS mutations in the Turkish population with non-small cell lung cancer and their response to erlotinib therapy. Balkan J Med Genet. 2018, 21:21-6. 10.2478\/bjmg-2018-0022","journal-title":"Balkan J Med Genet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3892\/or.2014.3406","article-title":"Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population","volume":"32","author":"Fakhruddin N","year":"2014","unstructured":"Fakhruddin N, Mahfouz R, Farhat F, et al.. Epidermal growth factor receptor and KRAS mutations in lung adenocarcinoma: a retrospective study of the Lebanese population. Oncol Rep. 2014, 32:2223-9. 10.3892\/or.2014.3406","journal-title":"Oncol Rep"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-012-0465-5","article-title":"EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study","volume":"33","author":"de Mello RA","year":"2012","unstructured":"de Mello RA, Pires FS, Marques DS, et al.. EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study. Tumour Biol. 2012, 33:2061-8. 10.1007\/s13277-012-0465-5","journal-title":"Tumour Biol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31829f6b4a","article-title":"Frequency and type of epidermal growth factor receptor mutations in moroccan patients with lung adenocarcinoma","volume":"8","author":"Errihani H","year":"2013","unstructured":"Errihani H, Inrhaoun H, Boukir A, et al.. Frequency and type of epidermal growth factor receptor mutations in moroccan patients with lung adenocarcinoma. J Thorac Oncol. 2013, 8:1212-4. 10.1097\/JTO.0b013e31829f6b4a","journal-title":"J Thorac Oncol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2012(05)03","article-title":"Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients","volume":"67","author":"Bacchi CE","year":"2012","unstructured":"Bacchi CE, Ciol H, Queiroga EM, Benine LC, Silva LH, Ojopi EB. Epidermal growth factor receptor and KRAS mutations in Brazilian lung cancer patients. Clinics (Sao Paulo). 2012, 67:419-24. 10.6061\/clinics\/2012(05)03","journal-title":"Clinics (Sao Paulo)"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31820a0ec0","article-title":"Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer","volume":"6","author":"Cote ML","year":"2011","unstructured":"Cote ML, Haddad R, Edwards DJ, et al.. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol. 2011, 6:627-30. 10.1097\/JTO.0b013e31820a0ec0","journal-title":"J Thorac Oncol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.8681","article-title":"Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma","volume":"16","author":"Zhou X","year":"2018","unstructured":"Zhou X, Cai L, Liu J, et al.. Analyzing EGFR mutations and their association with clinicopathological characteristics and prognosis of patients with lung adenocarcinoma. Oncol Lett. 2018, 16:362-70. 10.3892\/ol.2018.8681","journal-title":"Oncol Lett"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1245","article-title":"High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan","volume":"10","author":"Huang SF","year":"2004","unstructured":"Huang SF, Liu HP, Li LH, et al.. High frequency of epidermal growth factor receptor mutations with complex patterns in non-small cell lung cancers related to gefitinib responsiveness in Taiwan. Clin Cancer Res. 2004, 10:8195-203. 10.1158\/1078-0432.CCR-04-1245","journal-title":"Clin Cancer Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.04.044","article-title":"Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort","volume":"705","author":"Kaanane H","year":"2019","unstructured":"Kaanane H, El Attar H, Louahabi A, Berradi H, Idrissi HH, Khyatti M, Nadifi S. Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort. Gene. 2019, 705:36-43. 10.1016\/j.gene.2019.04.044","journal-title":"Gene"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000023","article-title":"Spectrum of EGFR mutation in lung adenocarcinoma in Morocco","volume":"8","author":"Elghissassi I","year":"2013","unstructured":"Elghissassi I, Errihani H. Spectrum of EGFR mutation in lung adenocarcinoma in Morocco. J Thorac Oncol. 2013, 8:e115-6. 10.1097\/JTO.0000000000000023","journal-title":"J Thorac Oncol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-020-06973-4","article-title":"Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer: a multi-institutional national retrospective study","volume":"20","author":"El Yacoubi H","year":"2020","unstructured":"El Yacoubi H, Sow ML, Kettani F, et al.. Frequency of anaplastic lymphoma kinase rearrangements in Moroccan patients with non small cell lung cancer: a multi-institutional national retrospective study. BMC Cancer. 2020, 20:479. 10.1186\/s12885-020-06973-4","journal-title":"BMC Cancer"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.4794","article-title":"Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non-small-cell lung cancer","volume":"36","author":"Solomon BJ","year":"2018","unstructured":"Solomon BJ, Kim DW, Wu YL, et al.. Final overall survival analysis from a study comparing first-line crizotinib versus chemotherapy in ALK-mutation-positive non-small-cell lung cancer. J Clin Oncol. 2018, 36:2251-8. 10.1200\/JCO.2017.77.4794","journal-title":"J Clin Oncol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis","volume":"19","author":"Conforti F","year":"2018","unstructured":"Conforti F, Pala L, Bagnardi V, et al.. Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis. Lancet Oncol. 2018, 19:737-46. 10.1016\/S1470-2045(18)30261-4","journal-title":"Lancet Oncol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djz094","article-title":"Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis","volume":"111","author":"Conforti F","year":"2019","unstructured":"Conforti F, Pala L, Bagnardi V, et al.. Sex-based heterogeneity in response to lung cancer immunotherapy: a systematic review and meta-analysis. J Natl Cancer Inst. 2019, 111:772-81. 10.1093\/jnci\/djz094","journal-title":"J Natl Cancer Inst"},{"key":"ref45","article-title":"Update in treatment of non small cell lung cancer (Article in French)","volume":"3","author":"Bosqu\u00e9e L","year":"2007","unstructured":"Bosqu\u00e9e L, Frusch N, Louis R. Update in treatment of non small cell lung cancer (Article in French). Rev Med Suisse. 2007, 3:1890-5.","journal-title":"Rev Med Suisse"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2013.10.644","article-title":"Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians (Article in French)","volume":"31","author":"Debieuvre D","year":"2014","unstructured":"Debieuvre D, Locher C, Neidhardt AC, et al.. Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians (Article in French). Rev Mal Respir. 2014, 31:805-16. 10.1016\/j.rmr.2013.10.644","journal-title":"Rev Mal Respir"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdf187","article-title":"Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases","volume":"13","author":"Radzikowska E","year":"2002","unstructured":"Radzikowska E, G\u0142az P, Roszkowski K. Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol. 2002, 13:1087-93. 10.1093\/annonc\/mdf187","journal-title":"Ann Oncol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.respe.2016.02.012","article-title":"Lung cancer: incidence and survival in Rabat, Morocco","volume":"64","author":"Lachgar A","year":"2016","unstructured":"Lachgar A, Tazi MA, Afif M, Er-Raki A, Kebdani T, Benjaafar N. Lung cancer: incidence and survival in Rabat, Morocco. Rev Epidemiol Sante Publique. 2016, 64:391-5. 10.1016\/j.respe.2016.02.012","journal-title":"Rev Epidemiol Sante Publique"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1378\/chest.1703770","article-title":"Lung cancer in nonsmoker women: clinical and survival patterns","volume":"144","author":"Duarte R","year":"2013","unstructured":"Duarte R, Monteiro A, Zamboni M. Lung cancer in nonsmoker women: clinical and survival patterns. Chest. 2013, 144:653A. 10.1378\/chest.1703770","journal-title":"Chest"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2007.25.18_suppl.7549","article-title":"Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials","volume":"25","author":"Albain KS","year":"2007","unstructured":"Albain KS, Unger J, Gotay CC, et al.. Toxicity and survival by sex in patients with advanced non-small cell lung carcinoma (NSCLC) on modern Southwest Oncology Group (SWOG) trials. J Clin Oncol. 2007, 25:7549. 10.1200\/jco.2007.25.18_suppl.7549","journal-title":"J Clin Oncol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/s1556-0864(15)31609-9","article-title":"Survival Differences by Sex for Patients with Advanced Non-small Cell Lung Cancer on Eastern Cooperative Oncology Group Trial 1594","volume":"1","author":"Wakelee HA","year":"2006","unstructured":"Wakelee HA, Wang W, Schiller, et al.. Survival Differences by Sex for Patients with Advanced Non-small Cell Lung Cancer on Eastern Cooperative Oncology Group Trial 1594. J Thorac Oncol. 2006, 1:441-6. 10.1016\/s1556-0864(15)31609-9","journal-title":"J Thorac Oncol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.038","article-title":"Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]","volume":"21","author":"Fukuoka M","year":"2003","unstructured":"Fukuoka M, Yano S, Giaccone G, et al.. Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. J Clin Oncol. 2003, 21:2237-46. 10.1200\/JCO.2003.10.038","journal-title":"J Clin Oncol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.16.2149","article-title":"Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial","volume":"290","author":"Kris MG","year":"2003","unstructured":"Kris MG, Natale RB, Herbst RS, et al.. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA. 2003, 290:2149-58. 10.1001\/jama.290.16.2149","journal-title":"JAMA"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv270","article-title":"First-line erlotinib versus gemcitabine\/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study","volume":"26","author":"Wu YL","year":"2015","unstructured":"Wu YL, Zhou C, Liam CK, et al.. First-line erlotinib versus gemcitabine\/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study. Ann Oncol. 2015, 26:1883-9. 10.1093\/annonc\/mdv270","journal-title":"Ann Oncol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70393-X","article-title":"Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial","volume":"13","author":"Rosell R","year":"2012","unstructured":"Rosell R, Carcereny E, Gervais R. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial. Lancet Oncol. 2012, 13:239-46. 10.1016\/S1470-2045(11)70393-X","journal-title":"Lancet Oncol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-014-0077-6","article-title":"EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition","volume":"33","author":"Rotella V","year":"2014","unstructured":"Rotella V, Fornaro L, Vasile E, et al.. EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition. J Exp Clin Cancer Res. 2014, 33:77. 10.1186\/s13046-014-0077-6","journal-title":"J Exp Clin Cancer Res"},{"key":"ref57","article-title":"Clinical model to predict progression-free survival in EGFR-mutant lung adenocarcinoma patients treated with first-generation EGFR-TKIs","volume":"5","author":"Cui S","year":"2016","unstructured":"Cui S, Xiong L, Lou Y, et al.. Clinical model to predict progression-free survival in EGFR-mutant lung adenocarcinoma patients treated with first-generation EGFR-TKIs. Transl Cancer Res\r\n. 2016, 5:476-85.","journal-title":"Transl Cancer Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4283-z","article-title":"Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial","volume":"18","author":"Mark\u00f3czy Z","year":"2018","unstructured":"Mark\u00f3czy Z, S\u00e1rosi V, Kudaba I, et al.. Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial. BMC Cancer. 2018, 18:598. 10.1186\/s12885-018-4283-z","journal-title":"BMC Cancer"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1177\/0300891619839292","article-title":"Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer","volume":"105","author":"Kwon BS","year":"2019","unstructured":"Kwon BS, Park JH, Kim S, et al.. Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer. Tumori. 2019, 105:216-24. 10.1177\/0300891619839292","journal-title":"Tumori"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2016.08.008","article-title":"Survival of Asian females with advanced lung cancer in the era of tyrosine kinase inhibitor therapy","volume":"18","author":"Becker DJ","year":"2017","unstructured":"Becker DJ, Wisnivesky JP, Grossbard ML, Chachoua A, Camidge DR, Levy BP. Survival of Asian females with advanced lung cancer in the era of tyrosine kinase inhibitor therapy. Clin Lung Cancer. 2017, 18:e35-40. 10.1016\/j.cllc.2016.08.008","journal-title":"Clin Lung Cancer"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2022.01.038","article-title":"A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands","volume":"165","author":"Ten Berge DM","year":"2022","unstructured":"Ten Berge DM, Aarts MJ, Groen HJ, Aerts JG, Kloover JS. A population-based study describing characteristics, survival and the effect of TKI treatment on patients with EGFR mutated stage IV NSCLC in the Netherlands. Eur J Cancer. 2022, 165:195-204. 10.1016\/j.ejca.2022.01.038","journal-title":"Eur J Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/327284-non-small-cell-lung-cancer-in-women-experience-from-the-national-institute-of-oncology-rabat-morocco","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T08:49:54Z","timestamp":1766134194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/327284-non-small-cell-lung-cancer-in-women-experience-from-the-national-institute-of-oncology-rabat-morocco"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":61,"URL":"https:\/\/doi.org\/10.7759\/cureus.99593","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,19]]}}}